EUVIMEDEUVIMED entdecken
Crossref

Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects

Yu Chang, Na Qiao, Qingqing Wang, Chan Bao, Yani Su, Xia Lei, Mingyi Yang, Yunfeng Hu

Oncology Research · 2026 · 1-10

DOI: 10.32604/or.2026.089420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Yu Chang und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chang, Y., Qiao, N., Wang, Q., Bao, C., Su, Y., Lei, X., Yang, M., & Hu, Y. (2026). Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.089420

Vancouver

Chang Y, Qiao N, Wang Q, Bao C, Su Y, Lei X, et al. Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.089420

BibTeX
@article{Chang2026,
  author = {Chang, Yu and Qiao, Na and Wang, Qingqing and Bao, Chan and Su, Yani and Lei, Xia and Yang, Mingyi and Hu, Yunfeng},
  title = {Patient-Derived Organoid Models in Cancer Immunotherapy: Current Progress, Challenges, and Translational Prospects},
  journal = {Oncology Research},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {1--10},
  doi = {10.32604/or.2026.089420}
}
Kostenlos starten →